MARY B KIRBY

Allopathic & Osteopathic Physicians|Family Medicine NEW BERN, NC NPI 1104872316

General Payments — all program years on this page

$2,242.07

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 138
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $402.43 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $402.4317

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $232.8915
2019 $566.7931
2020 $148.8511
2021 $241.8327
2022 $231.8715
2023 $417.4122
2024 $402.4317

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086130882 Bayer Healthcare Pharmaceuticals Inc. $18.00 09/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097501077 Novo Nordisk Inc $18.60 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104080052 ABBVIE INC. $23.34 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104080054 ABBVIE INC. $24.78 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104080056 ABBVIE INC. $22.05 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105693339 AstraZeneca Pharmaceuticals LP $17.11 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116496146 GlaxoSmithKline, LLC. $17.27 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117298299 Amgen Inc. $15.05 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117298301 Amgen Inc. $14.67 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117875187 Boehringer Ingelheim Pharmaceuticals, Inc. $20.45 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131152036 PFIZER INC. $19.51 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135194384 Lilly USA, LLC $17.33 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148302654 Axsome Therapeutics, Inc. $22.76 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148302656 Axsome Therapeutics, Inc. $16.20 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148302658 Axsome Therapeutics, Inc. $16.26 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150148045 SHIELD THERAPEUTICS INC $105.83 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153320506 Dexcom, Inc. $13.22 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.